7 insiders reported 42 Form 4 transactions for Replimune Group, Inc. (REPL) over the past 18 months (most recent 2026-08-19). Recent activity: Hill Emily Luisa (Chief Financial Officer) Sell 9,256 shares, Hill Emily Luisa (Chief Financial Officer) Sell 11,448 shares, Patel Sushil (Chief Executive Officer) Sell 39,341 shares, Xynos Konstantinos (Chief Medical Officer) Sell 11,447 shares, Schwendenman Andrew (Chief Accounting Officer) Sell 7,632 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Hill Emily Luisa | Chief Financial Officer | Sell | 9,256 | $132,176 |
| 2026-08-12 | Hill Emily Luisa | Chief Financial Officer | Sell | 11,448 | $148,481 |
| 2026-08-12 | Patel Sushil | Chief Executive Officer | Sell | 39,341 | $510,253 |
| 2026-08-12 | Xynos Konstantinos | Chief Medical Officer | Sell | 11,447 | $148,468 |
| 2026-08-12 | Schwendenman Andrew | Chief Accounting Officer | Sell | 7,632 | $98,987 |
| 2026-06-03 | Sarchi Christopher | Chief Commercial Officer | Sell | 12,000 | $110,880 |
| 2026-05-20 | Patel Sushil | Chief Executive Officer | Sell | 37,324 | $189,606 |
| 2026-05-20 | Hill Emily Luisa | Chief Financial Officer | Sell | 7,812 | $39,685 |
| 2026-05-20 | Astley-Sparke Philip | Director | Sell | 17,657 | $89,698 |
| 2026-05-20 | Xynos Konstantinos | Chief Medical Officer | Sell | 14,023 | $71,237 |
| 2026-05-20 | Schwendenman Andrew | Chief Accounting Officer | Sell | 7,894 | $40,102 |
| 2026-05-20 | Sarchi Christopher | Chief Commercial Officer | Sell | 8,626 | $43,820 |
| 2026-04-07 | Hill Emily Luisa | Chief Financial Officer | Buy | 50,000 | $0 |
| 2026-04-07 | Patel Sushil | Chief Executive Officer | Buy | 251,240 | $0 |
| 2026-04-07 | Xynos Konstantinos | Chief Medical Officer | Buy | 50,000 | $0 |
| 2026-04-07 | Schwendenman Andrew | Chief Accounting Officer | Sell | 36,667 | $0 |
| 2026-04-07 | Sarchi Christopher | Chief Commercial Officer | Buy | 50,000 | $0 |
| 2026-04-07 | Astley-Sparke Philip | Director | Buy | 50,000 | $0 |
| 2026-04-06 | Sarchi Christopher | Chief Commercial Officer | Sell | 6,500 | $52,065 |
| 2026-02-20 | Astley-Sparke Philip | Director | Sell | 25,000 | $0 |
| 2025-12-19 | Sarchi Christopher | Chief Commercial Officer | Buy | 35,000 | $0 |
| 2025-12-19 | Patel Sushil | Chief Executive Officer | Buy | 200,000 | $0 |
| 2025-12-19 | Xynos Konstantinos | Chief Medical Officer | Buy | 60,000 | $0 |
| 2025-12-19 | Hill Emily Luisa | Chief Financial Officer | Buy | 60,000 | $0 |
| 2025-12-19 | Schwendenman Andrew | Chief Accounting Officer | Buy | 10,000 | $0 |
Source: SEC Form 4 filings · as of 2026-08-19